Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01673
Species: Homo sapiens
Position : chr12:121803095-121805690
Year: 2023
Title: Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis.
Genome Build: hg38
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: hepatocellular carcinoma
PMID:  37756562
MONDO: MONDO:0007256
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: SNU-387
CVCL ID: CVCL_0250
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: SE functional perturbation; LINC01089-dependent metastatic phenotype; In vivo functional validation
High Throughput Method: H3K27ac ChIP-seq; RNA-seq
Low Throughput Method: CRISPRi; RT-qPCR; migration/invasion assay; in vivo metastasis assay; In vivo phenotyping
About Target Gene
Target gene : LINC01089
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 6 found
Enhancer ID Position Tissue Cell Disease
E_01639 chr12:121803095-121805690 liver hepatocyte hepatocellular carcinoma
E_01640 chr12:121803095-121805690 liver malignant cell hepatocellular carcinoma
E_01641 chr12:121803095-121805690 liver malignant cell hepatocellular carcinoma
E_01642 chr12:121803095-121805690 liver malignant cell hepatocellular carcinoma
E_01671 chr12:121803095-121805690 liver hepatocyte hepatocellular carcinoma
E_01672 chr12:121803095-121805690 liver malignant cell hepatocellular carcinoma
Expression of Target Genes for the Enhancer